Literature DB >> 2880630

Late onset involuntary movements in chronic schizophrenia: relationship of 'tardive' dyskinesia to intellectual impairment and negative symptoms.

J L Waddington, H A Youssef.   

Abstract

Intellectual impairment, negative symptoms, and medication history were assessed in chronic schizophrenic patients with and without abnormal involuntary movements (tardive dyskinesia). Patients with involuntary movements had received neither longer nor more intensive treatment with neuroleptics or anticholinergics. However, the presence or absence of involuntary movements was prominently associated with the presence or absence of intellectual impairment/negative symptoms; these features are characteristic of the defect state/type II syndrome of schizophrenia, in which structural abnormalities of the brain may be over-represented. The role of subtle organic changes in conferring vulnerability to the emergence of such involuntary movements should be re-evaluated.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2880630     DOI: 10.1192/bjp.149.5.616

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  12 in total

1.  Off-label antipsychotic use and tardive dyskinesia in at-risk populations: new drugs with old side effects.

Authors:  Gary Remington; Margaret Hahn
Journal:  J Psychiatry Neurosci       Date:  2014-01       Impact factor: 6.186

2.  Topographic subtypes of tardive dyskinesia in schizophrenic patients aged less than 60 years: relationship to demographic, clinical, treatment, and neuropsychological variables.

Authors:  O Gureje
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-12       Impact factor: 10.154

3.  Involuntary orofacial movements in hospitalised patients with mental handicap or epilepsy: relationship to developmental/intellectual deficit and presence or absence of long-term exposure to neuroleptics.

Authors:  H A Youssef; J L Waddington
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

Review 4.  Effect of neuroleptics on positive and negative symptoms and the deficit state.

Authors:  J Angst; H H Stassen; B Woggon
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Chronic neuroleptic effects on spatial reversal learning in monkeys.

Authors:  E D Levin; L M Gunne
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 6.  The ageing brain, neuroleptic drugs and the enigma of schizophrenia.

Authors:  J L Waddington
Journal:  Ir J Med Sci       Date:  1988-05       Impact factor: 1.568

7.  Movements in never-medicated schizophrenics: a preliminary study.

Authors:  D S Fenn; D Moussaoui; W F Hoffman; N Kadri; B Bentounssi; A Tilane; M Khomeis; D E Casey
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

8.  An evaluation of cranial CT scanning in clinical psychiatry.

Authors:  H Colohan; E O'Callaghan; C Larkin; J L Waddington
Journal:  Ir J Med Sci       Date:  1989-07       Impact factor: 1.568

9.  Relations between movement disorders and psychopathology under predominantly atypical antipsychotic treatment in adolescent patients with schizophrenia.

Authors:  Stefan Gebhardt; Fabian Härtling; Markus Hanke; Frank M Theisen; Richard von Georgi; Phillip Grant; Markus Mittendorf; Matthias Martin; Christian Fleischhaker; Eberhard Schulz; Helmut Remschmidt
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-09-14       Impact factor: 4.785

10.  Iron status, movement disorders, and acute phase response in elderly psychiatric patients.

Authors:  A J Treloar; M A Crook; P Tutt; D P White; M P Philpot
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.